Enhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem

Kai Zhang,Xiangdan Meng,Zhou Yang,Haifeng Dong,Xueji Zhang

DOI: https://doi.org/10.1016/j.biomaterials.2020.120278

IF: 14

2020-11-01

Biomaterials

Abstract:<p>Tumor hypoxia-responsive size-switchable nanosystems for precise delivery of drug into deep tumor show great prospects for killing cancer cells with high specificity and minimal invasiveness. However, the development of versatile nanosystems is still a challenge. Herein, for the first time, we report a novel hypoxia-responsive copper metal-organic framework nanoparticles (Cu-MOF NPs) for chemodynamic therapy and sonodynamic therapy (CDT/SDT). The large size Cu-MOF NPs show good stability under normal oxygen partial pressure and enhance tumor accumulation, and it quickly degraded and released Cu²⁺ and Ce6 when exposed to the hypoxic tumor microenvironment (TME), significantly reinforced the intratumoral penetration. The internalized Cu²⁺ reacts with local GSH to deplete GSH and reduce Cu²⁺ to Cu⁺, which subsequently reacts with endogenous H₂O₂ to produce cytotoxic hydroxyl radicals (•OH) through Fenton-like reaction for CDT. The released Ce6 further mediated SDT under US irradiation. The synergistic SDT/CDT efficacy was significantly enhanced owing to the GSH depletion, realizing selective and effective MCF-7 killing with minimal invasiveness. This work presents a novel hypoxia-responsive MOF nanosystem with intrinsic CDT properties, mainly, the MOF nanosystem is flexible to the integration with other therapy approaches. It provides a general strategy to design a hypoxia-responsive MOF nano theranostic platform.</p>

engineering, biomedical,materials science, biomaterials

What problem does this paper attempt to address?

This paper aims to solve some key problems in tumor treatment, especially how to improve the permeability and selectivity of drugs within tumors while reducing damage to normal tissues. Specifically, the researchers have developed a new type of copper - metal - organic framework nano - system (Cu - MOF NPs). This nano - system can be degraded responsively in the hypoxic tumor microenvironment, thereby releasing Cu\(^{2+}\) and photosensitizer Ce6, achieving the synergistic effect of chemodynamic therapy (CDT) and sonodynamic therapy (SDT).

### Main Problems and Solutions
1. **Insufficient Tumor Permeability**:
- **Problem**: Traditional nanocarriers are difficult to penetrate deep into tumors due to their large size, resulting in insufficient drug concentration in the central area of the tumor.
- **Solution**: A large Cu - MOF NPs that is stable under normal oxygen conditions was designed. After entering the hypoxic tumor microenvironment, it can be rapidly degraded to release small - molecule drugs, enhancing the permeability within the tumor.

2. **Selective Killing of Cancer Cells**:
- **Problem**: Traditional chemotherapy drugs also have relatively large toxic and side effects on normal tissues.
- **Solution**: By reacting Cu\(^{2+}\) with high - concentration glutathione (GSH) in tumor cells, GSH is consumed and cytotoxic hydroxyl radicals (·OH) are generated, achieving the selective killing of cancer cells. Meanwhile, the released Ce6 generates singlet oxygen (\(^1\)O\(_2\)) under ultrasonic irradiation, further enhancing the treatment effect.

3. **Improving Treatment Efficiency**:
- **Problem**: A single treatment method often has limited effectiveness.
- **Solution**: Combining the two treatment methods of CDT and SDT, through GSH depletion and singlet oxygen generation, the treatment effect is significantly enhanced, achieving the selective and efficient killing of MCF - 7 breast cancer cells.

### Experimental Results
- **In vitro experiments**: Cu - MOF/Ce6 shows a higher drug - release efficiency under hypoxic conditions and exhibits significant cytotoxicity in MCF - 7 cells, while having lower toxicity to normal cells (such as NHDF).
- **In vivo experiments**: In the tumor - bearing mouse model, Cu - MOF/Ce6 combined with ultrasonic irradiation shows the best tumor - inhibition effect. The tumor volume is significantly reduced, and no obvious change in body weight is observed, indicating its good biocompatibility and low toxicity.

### Conclusion
This research has successfully developed a new type of hypoxia - responsive copper - metal - organic framework nano - system. Through responsive degradation in the tumor microenvironment, it realizes the efficient release of drugs and deep tumor penetration, significantly improving the specificity and effectiveness of tumor treatment. This achievement provides new ideas for designing multi - functional tumor - treatment platforms.